Research and Development Department, Hygieia Innovation Sdn. Bhd, Lot 1G-2G, Komplex Lanai, No.2, Persiaran Seri Perdana, Persint 10, Territory of Putrajaya, 62250 Federal, Malaysia.
Stem Cells Int. 2012;2012:423868. doi: 10.1155/2012/423868. Epub 2012 May 9.
Induced pluripotent stem cell-based therapy for treating genetic disorders has become an interesting field of research in recent years. However, there is a paucity of information regarding the applicability of induced pluripotent stem cells in dental research. Recent advances in the use of induced pluripotent stem cells have the potential for developing disease-specific iPSC lines in vitro from patients. Indeed, this has provided a perfect cell source for disease modeling and a better understanding of genetic aberrations, pathogenicity, and drug screening. In this paper, we will summarize the recent progress of the disease-specific iPSC development for various human diseases and try to evaluate the possibility of application of iPS technology in dentistry, including its capacity for reprogramming some genetic orodental diseases. In addition to the easy availability and suitability of dental stem cells, the approach of generating patient-specific pluripotent stem cells will undoubtedly benefit patients suffering from orodental disorders.
基于诱导多能干细胞的治疗遗传性疾病的方法已成为近年来一个颇受关注的研究领域。然而,关于诱导多能干细胞在牙科研究中的应用,相关信息却非常有限。最近,在诱导多能干细胞的应用方面取得了一些进展,使得我们有可能从患者体外开发出针对特定疾病的诱导多能干细胞系。实际上,这为疾病建模和更好地理解遗传异常、致病性和药物筛选提供了理想的细胞来源。在本文中,我们将总结各种人类疾病的特定疾病诱导多能干细胞的最新研究进展,并尝试评估 iPS 技术在牙科中的应用可能性,包括其对某些遗传性口腔疾病的重编程能力。除了易于获取和适合的牙科干细胞之外,生成患者特异性多能干细胞的方法无疑将使遭受口腔疾病困扰的患者受益。